Zeitschrift für Gastroenterologie

---

• 1. Fibrogenesis

A1.1

Puengel, T; Krenkel, O; Mossanen, J; Longerich, T; Lefebvre, E; Trautwein, C; Tacke, F:

Der duale CCR2/CCR5 Antagonist Cenicriviroc reduziert Steatohepatitis und Fibrose durch Inhibition infiltrierender pro-inflammatorischer CCR2+ Monozyten in Mausmodellen der chronischen Leberschädigung

• Abstract
• HTML

A1.2

Ghallab, A; Reif, R; Hassan, R; Seddek, AS; Hengstler, JG:

In vivo imaging of liver injury and regeneration by functional two-photon microscopy

• Abstract
• HTML

A1.3

Hahn, L; Churin, Y; Drebber, U; Herebian, D; Mayatepek, E; Roderfeld, M; Roeb, E:

Interleukin-13 Depletion normalisiert den enterohepatischen Gallensäurekreislauf in Abcb4 knockout Mäusen

• Abstract
• HTML

A1.4

Roderfeld, M; Zahner, D; Glimm, H; Churin, Y; Tschuschner, A; Herebian, D; Mayatepek, E; Roeb, E:

Eine Transgen induzierte unfolded protein response (UPR) steigert Leberschädigung und Karzinogenese im Cholestase-Maus Modell

• Abstract
• HTML

A1.5

Mahli, A; Freese, K; Thasler, WE; Bergheim, I; Hellerbrand, C:

Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis

• Abstract
• HTML

A1.6

Freese, K; Thasler, WE; Hellerbrand, C:

Increased expression of pregnancy-associated plasma protein-A (PAPP-A) in hepatic stellate cells correlates with hepatic fibrosis and can be detected in the serum of patients with liver disease

• Abstract
• HTML

A1.7

Hartwig, VA; Dewidar, B; Kluth, A; Tappenbeck, N; Dropmann, A; Meyer, C; Meindl-Beinker, NM; Dooley, S:

ABCB5+ mesenchymal stem cell transplantation in a chronic liver disease mouse model

• Abstract
• HTML

A1.8

Dropmann, A; Dewidar, B; Dediulia, T; Korhonen, H; Janicot, M; Piiper, A; Jones, D; Brain, J; Gaiser, T; Weiss, TS; Ebert, M; Dooley, S; Meindl-Beinker, NM:

Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver disease

• Abstract
• HTML

A1.9

Cheng, Y; Zhu, X; Tuma-Kellner, S; Stremmel, W; Chamulitrat, W:

aP2-specific inactivation of fatty acid transport protein 4 in mice sensitizes hepatic fibrogenesis under methionine and choline-deficient diet

• Abstract
• HTML

A1.10

Krawczyk, M; Kaminska, D; Janczyk, W; Lammert, F; Socha, P:

Biopsy-based analysis of the prosteatotic TM6SF2 p.E167K and PNPLA3 p.I148 M gene variants as potential modifiers of Wilson disease

• Abstract
• HTML

A1.11

Krawczyk, M; Rau, M; Schattenberg, JM; Bantel, H; Pathil, A; Demir, M; Kluwe, J; Boettler, T; Lammert, F; Geier, A:

Presence of the MBOAT7 rs641738 variant might enhance liver fibrosis in patients with fatty liver: analysis of the German NAFLD CSG cohort

• Abstract
• HTML

A1.12

Schüller, F; Tacke, F; Lüdde, T; Trautwein, C; Roderburg, C:

Die microRNA „miR-122“ spielt keine Rolle bei der Aktivierung von hepatischen Sternzellen

• Abstract
• HTML

A1.13

Neß, M; Meurer, SK; Bangen, JM; Huber, M; Liedtke, C; Weiskirchen, R:

Differentiation and effects of TGF-β1 and IL-3 signaling on primary murine endoglin deficient mast cells

• Abstract
• HTML

A1.14

Meurer, SK; Neß, M; Weiskirchen, R:

Hepatic stellate cells down-regulate pro-apoptotic effector abundance and secretion in mast cells

• Abstract
• HTML

A1.15

Meurer, SK; Weiskirchen, R:

Primary peritoneal mast cells (PMC) reduce the fibrogenic response of hepatic stellate cells while inducing caspase 3 cleavage and activity

• Abstract
• HTML

A1.16

Asimakopoulou, A; Fülöp, A; Borkham-Kamphorst, E; Van de Leur, E; Gassler, N; Berger, T; Beine, B; Meyer, HE; Mak, TW; Hopf, C; Henkel, C; Weiskirchen, R:

Lipocalin 2 (LCN2)-deficient mice are more prone to hepatic steatosis: LCN2 and mitochondrial and peroxisomal integrity

• Abstract
• HTML

A1.17

Borkham-Kamphorst, E; Van de Leur, E; Haas, U; Weiskirchen, R:

The CYR61/CTGF/NOV (CCN) family members induce endoplasmic reticulum stress and unfolded protein response

• Abstract
• HTML

A1.18

Lambertz, J; Borkham-Kamphorst, E; Weiskirchen, R:

Untersuchung von Lipocalin 2 und Perilipin 5 in der Fruktose-induzierten Nichtalkoholischen Fettlebererkrankung

• Abstract
• HTML

A1.19

Malik, IA; Asif, AR; Ramadori, G; Wilting, J:

Effects of radiation and/or tumor necrosis factor alpha on cell damage in a healthy liver: a role for PECAM-1

• Abstract
• HTML

A1.20

Bowe, A; Mueck, V; Curth, H; Goeser, T; Nierhoff, D:

Expression of the oncofetal marker Nope in the regenerating adult murine liver after disruption of interhepatocytic gap junctions via bile duct ligation

• Abstract
• HTML

A1.21

Leven, AS; Schlattjan, J; Sowa, JP; Kucukoglu, O; Hasenberg, T; Bechmann, L; Gerken, G; Canbay, A:

Fibrosis in adipose tissue is correlated to liver injury in NAFLD

• Abstract
• HTML

A1.22

Gehrke, N; Hövelmeyer, N; Waisman, A; Galle, PR; Schattenberg, JM:

Generation and functional analyses of hepatocyte-specific type I interleukin-1 receptor (IL-1RI) knockout mice

• Abstract
• HTML

A1.23

Hall, RA; Hochrath, K; Lammert, F; Grünhage, F:

Genetic analysis of spontaneous (non-toxic) liver fibrosis in a congenic mouse intercross

• Abstract
• HTML

A1.24

Ramadori, P; Drescher, H; Erschfeld, S; Fragoulis, A; Kensler, TW; Wruck, CJ; Trautwein, C; Kroy, DC:

Hepatic Nrf2 overexpression inhibits the deleterious effects induced by c-met deficiency in the progression of NASH

• Abstract
• HTML

A1.25

Becker, E; Di Fazio, P; Hänze, J; Bartsch, DK; Gress, T; Wissniowski, TT:

Hypoxia causes hepatic stellate cells activation in the absence of CUX1

• Abstract
• HTML

A1.26

Kulawik, A; Engesser, R; Raue, A; Ehlting, C; Albrecht, U; Gaestel, M; Klingmüller, U; Häussinger, D; Timmer, J; Bode, JG:

IL-1β induced activation of the p38MAPK/MK2 pathway in hepatocytes and macrophages: a mathematical model of cell-type-specific signal transduction

• Abstract
• HTML

A1.27

Berkhout, L; Krech, T; Tiegs, G; Barikbin, R:

Inflammation and Fibrosis in the Livers of TNFR1/Mdr2ko Mice

• Abstract
• HTML

A1.28

Stephanie, W; Häussinger, D; Bode, JG:

Influence of hepatocytes on macrophage differentiation

• Abstract
• HTML

A1.29

Klein, S; Hinüber, C; Hittatiya, K; Schierwagen, R; Uschner, FE; Strassburg, CP; Fischer, HP; Spengler, U; Trebicka, J:

Novel rat model of repetitive portal venous embolization mimicking human non-cirrhotic idiopathic portal hypertension

• Abstract
• HTML

A1.30

Frissen, M; Liao, L; Bieghs, V; Trautwein, C:

Role of NLRP3 inflammasome activation during cholestatic liver injury

• Abstract
• HTML

A1.31

Othman, A; Meyer, C; Telfah, A; Lambert, J; Hergenröder, R; Dooley, S; Hammad, S:

Tamoxifen is critical as inducer of Cre activity in mouse models for hepatotoxicity studies

• Abstract
• HTML

A1.32

Reissing, J; Kroy, D; Berres, ML; Strnad, P; Trautwein, C; Zimmermann, HW:

Th2-polarization of CD4+ T-cells is locally induced and drives liver fibrogenesis

• Abstract
• HTML

A1.33

Wang, L; Steinheuer, L; Ulmer, B; Yu, X; Eischeid, H; Buettner, R; Odenthal, M:

The Epigenetic Modifications by the Histone Demethylase LSD1 in Hepatic Stellate Cells Contribute to Liver Fibrosis

• Abstract
• HTML

A1.34

Ravichandran, G; Tiegs, G; Barikbin, R:

The Role of IFNγ in the Immune Pathogenesis of Primary Sclerosing Cholangitis

• Abstract
• HTML

A1.35

Manka, PP; Coombes, JD; Bechmann, L; Swiderska-Syn, M; Reid, D; Claridge, LC; Younis, R; Mehta, K; Briones, MA; Kitamura, N; Mi, Z; Kuo, PC; Williams, R; Eksteen, B; Diehl, AM; Gerken, G; Canbay, A; Flamant, F; Gauthier, K; Syn, WK:

Thyroid Hormone Receptor (TR): a regulator in Liver Fibrogenesis

• Abstract
• HTML

A1.36

Maass, T; Itzel, T; Evert, M; Meister, G; Teufel, A:

Time course Analyse der miRNA-Expression bei der PDGF-B vermittelten Leberfibrogenese

• Abstract
• HTML